NutriBand Inc.
NTRBNasdaqCIK 1676047HealthcareFiscal year ends Jan 31
Reports and events: 152 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-06-2622:00 ET | S-1/A | Registration statement, amended | 0001213900-23-051508 |
| 2023-06-2115:50 ET | 8-K/A | 7.01 Regulation FD disclosure | 0001213900-23-050464 |
| 2023-06-0917:20 ET | 10-Q | Quarterly reportPeriod 2023-04-30 | 0001213900-23-047881 |
| 2023-05-1021:14 ET | S-1 | Registration statement | 0001213900-23-037820 |
| 2023-04-2610:30 ET | 10-K | Annual reportPeriod 2023-01-31 | 0001213900-23-032682 |
| 2023-03-2911:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-23-023937 |
| 2023-01-0511:23 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-23-001034 |
| 2022-12-3016:02 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001213900-22-084014 |
| 2022-12-0216:20 ET | 10-Q | Quarterly reportPeriod 2022-10-31 | 0001213900-22-077324 |
| 2022-10-3116:24 ET | DEF 14A | Proxy statementPeriod 2022-12-09 | 0001213900-22-067690 |
| 2022-10-0611:46 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-22-062369 |
| 2022-09-0817:54 ET | 10-Q | Quarterly reportPeriod 2022-07-31 | 0001213900-22-054592 |
| 2022-08-1916:21 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors | 0001213900-22-049711 |
| 2022-08-1008:02 ET | 8-K | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-22-046093 |
| 2022-08-0108:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-22-043166 |
| 2022-07-2708:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-22-041867 |
| 2022-07-2608:08 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-22-041488 |
| 2022-07-1510:42 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-22-039511 |
| 2022-05-3117:20 ET | 10-Q | Quarterly reportPeriod 2022-04-30 | 0001213900-22-030469 |
| 2022-04-2918:17 ET | 10-K | Annual reportPeriod 2022-01-31 | 0001213900-22-022425 |
| 2022-01-3108:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-22-004373 |
| 2022-01-2717:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-22-004031 |
| 2022-01-1010:53 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-22-001256 |
| 2022-01-0312:07 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-22-000118 |
| 2021-12-3012:55 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-21-068055 |
| 2021-12-1417:02 ET | 10-Q | Quarterly reportPeriod 2021-10-31 | 0001213900-21-065228 |
| 2021-12-0916:12 ET | DEF 14A | Proxy statementPeriod 2022-01-21 | 0001213900-21-064409 |
| 2021-10-1216:57 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-21-052451 |
| 2021-10-0817:03 ET | 8-K | 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001213900-21-052092 |
| 2021-10-0116:28 ET | 8-K | 8.01 Other events | 0001213900-21-051123 |
| 2021-10-0119:07 ET | S-1/A | Registration statement, amended | 0001213900-21-050881 |
| 2021-09-2917:24 ET | S-1/A | Registration statement, amended | 0001213900-21-050636 |
| 2021-09-2717:45 ET | S-1 | Registration statement | 0001213900-21-050056 |
| 2021-09-0315:31 ET | 10-Q | Quarterly reportPeriod 2021-07-31 | 0001213900-21-046610 |
| 2021-09-0117:11 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-21-046170 |
| 2021-06-1417:05 ET | 10-Q | Quarterly reportPeriod 2021-04-30 | 0001213900-21-032333 |
| 2021-04-0217:28 ET | 10-K | Annual reportPeriod 2021-01-31 | 0001213900-21-019991 |
| 2021-03-1111:10 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-21-014753 |
| 2021-01-2207:32 ET | 8-K/A | 3.02 Unregistered sale of equity | 0001213900-21-003605 |
| 2021-01-2117:29 ET | 8-K/A | 3.02 Unregistered sale of equity | 0001213900-21-003531 |
| 2021-01-2115:24 ET | 8-K | 3.02 Unregistered sale of equity | 0001213900-21-003428 |
| 2021-01-1219:28 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001213900-21-001545 |
| 2020-12-1515:13 ET | 10-Q | Quarterly reportPeriod 2020-10-31 | 0001213900-20-042751 |
| 2020-09-1116:32 ET | 10-Q | Quarterly reportPeriod 2020-07-31 | 0001213900-20-026264 |
| 2020-09-0414:58 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-20-025377 |
| 2020-06-0415:02 ET | 10-Q | Quarterly reportPeriod 2020-04-30 | 0001213900-20-014088 |
| 2020-05-2717:06 ET | S-1/A | Registration statement, amended | 0001213900-20-013543 |
| 2020-05-1919:06 ET | S-1/A | Registration statement, amended | 0001213900-20-012861 |
| 2020-04-1617:27 ET | S-1 | Registration statement | 0001213900-20-009370 |
| 2020-04-1411:11 ET | 10-K | Annual reportPeriod 2020-01-31 | 0001213900-20-009139 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.